Abstract
INVASIVE INFECTIONS WITH METHICILLIN-RESISTANT STAPHYlococcus aureus (MRSA) have become a focus of national attention over the past several years due to their potentially lethal complications and reports indicating that their frequency is on the rise in most US hospitals. Hospitalizations with infections due to MRSA steadily increased between 2000 and 2005, nearly doubling in many areas of the country. Klevens et al estimated that up to 18 650 deaths in the United States in 2005 may have been associated with invasive MRSA infection. These statistics coupled with the increasing number of outbreaks of MRSA infections in community settings have helped ignite a contentious public debate about the best means of control, including calls for increased surveillance for MRSA infections, new prevention activities such as screening of all patients admitted to hospitals to detect colonization with MRSA (universal screening), and public reporting of hospitalacquired MRSA infections. Now amidst this alarm, the report by Burton and colleagues in this issue of JAMA documents decreases in the rate of MRSA-related central line–associated bloodstream infections (CLABSI) in hospitals participating in a voluntary surveillance network. This network was initially known as the National Nosocomial Infection Surveillance system (NNIS, 1997-2004) and later as the National Healthcare Safety Network (NHSN, 2006-2007). Facilities participating in NNIS/NSHN report to the Centers for Disease Control and Prevention (CDC) all health care–acquired infections detected during prospective surveillance in a variety of units. The current report details the experience with MRSA CLABSI in intensive care units (ICUs) from 1997 to 2007 and demonstrates that despite an overall increase in the incidence of MRSA infections, the rate of MRSA CLABSI decreased 49.6% at NNIS/NSHN hospitals. Four types of ICUs (surgical, cardiothoracic, coronary, and medical/surgical without a major teaching affiliation) initially experienced an increase in MRSA CLABSI lasting until 2001, but this was followed by declining rates through 2007. All units, except pediatric ICUs, experienced an overall decline in infections from 2002-2007. Moreover, both the overall rate of CLABSI and methicillin-sensitive S aureus (MSSA) CLABSI showed steady declines from 1997 to 2007 among all types of ICUs. Although the report by Burton et al suggests ICUs are having increasing success limiting the spread of MRSA, the study is not without limitations. The first concern is the dynamic nature of NNIS/NHSN. Fewer than 6% of ICUs in the current study participated in the NNIS/NHSN for the entire 11-year study interval. A large number of hospitals entered the network for the first time in 2007 prompted by mandatory public reporting requirements in many states, highlighting the changing nature of the network and challenging its description as a voluntary, hospital-based reporting system. In addition, although the authors contend that voluntary self-reporting was most likely accurate, it has not been validated since 1998. The accuracy of selfreporting may be an important issue in the upcoming era of mandatory public reporting and increased scrutiny of hospital-acquired infections by regulatory agencies. The study also leaves the unsettling realization that the observed reductions in infection cannot be attributed to any particular intervention. Previous reports from NNISparticipating ICUs have demonstrated reductions in bloodstream infections, ventilator-associated pneumonias, and catheter-associated urinary tract infections. These reports have led to the conclusion that prospective surveillance followed by careful local risk assessment and adoption of interventions that include best practices can be used to reduce hospital-acquired infection rates. It is likely that the reductions in infections reported by Burton et al were related to a range of interventions that have been implemented during the last decade including better hand hygiene practices, adoption of standardized line insertion and care practices, proper barrier precautions, improved catheter technology, and shorter periods of indwelling catheter use in patients. Thus, it is impossible to determine which practices had the greatest effect or even which were implemented by participating ICUs. Can the end be justified by the means, when the means are unknown?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.